| Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia P Theunissen, E Mejstrikova, L Sedek, AJ van der Sluijs-Gelling, G Gaipa, ... Blood, The Journal of the American Society of Hematology 129 (3), 347-357, 2017 | 392 | 2017 |
| Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a … M Brüggemann, M Kotrova, H Knecht, J Bartram, M Boudjogrha, V Bystry, ... Leukemia 33 (9), 2241-2253, 2019 | 225 | 2019 |
| Minimal residual disease in adult ALL: technical aspects and implications for correct clinical interpretation M Brüggemann, M Kotrova Hematology 2014, the American Society of Hematology Education Program Book …, 2017 | 160 | 2017 |
| Library preparation for next generation sequencing: A review of automation strategies JF Hess, TA Kohl, M Kotrová, K Rönsch, T Paprotka, V Mohr, ... Biotechnology advances 41, 107537, 2020 | 156 | 2020 |
| The predictive strength of next-generation sequencing MRD detection for relapse compared with current methods in childhood ALL M Kotrova, K Muzikova, E Mejstrikova, M Novakova, ... Blood, The Journal of the American Society of Hematology 126 (8), 1045-1047, 2015 | 112 | 2015 |
| Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS B Scheijen, RWJ Meijers, J Rijntjes, MY van der Klift, M Möbs, ... Leukemia 33 (9), 2227-2240, 2019 | 107 | 2019 |
| Next-generation sequencing indicates false-positive MRD results and better predicts prognosis after SCT in patients with childhood ALL M Kotrova, VHJ Van Der Velden, JJM Van Dongen, R Formankova, ... Bone marrow transplantation 52 (7), 962-968, 2017 | 93 | 2017 |
| Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS H Knecht, T Reigl, M Kotrová, F Appelt, P Stewart, V Bystry, A Krejci, ... Leukemia 33 (9), 2254-2265, 2019 | 91* | 2019 |
| ETV6/RUNX1‐like acute lymphoblastic leukemia: A novel B‐cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype M Zaliova, M Kotrova, S Bresolin, J Stuchly, J Stary, O Hrusak, ... Genes, Chromosomes and Cancer 56 (8), 608-616, 2017 | 78 | 2017 |
| Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1 S Reinke, PJ Bröckelmann, I Iaccarino, M Garcia-Marquez, S Borchmann, ... Blood, The Journal of the American Society of Hematology 136 (25), 2851-2863, 2020 | 62 | 2020 |
| Is next-generation sequencing the way to go for residual disease monitoring in acute lymphoblastic leukemia? M Kotrova, J Trka, M Kneba, M Brüggemann Molecular diagnosis & therapy 21 (5), 481-492, 2017 | 58 | 2017 |
| Polyclonal, newly derived T cells with low expression of inhibitory molecule PD-1 in tonsils define the phenotype of lymphocytes in children with Periodic Fever, Aphtous … D Petra, K Petra, K Michaela, K Daniela, H Petr, K Ladislav, K Rami, ... Molecular immunology 65 (1), 139-147, 2015 | 56 | 2015 |
| The TREC/KREC assay for the diagnosis and monitoring of patients with DiGeorge syndrome E Froňková, A Klocperk, M Svatoň, M Nováková, M Kotrová, J Kayserová, ... Plos one 9 (12), e114514, 2014 | 38 | 2014 |
| Distinct bilineal leukemia immunophenotypes are not genetically determined M Kotrova, A Musilova, J Stuchly, K Fiser, J Starkova, E Mejstrikova, ... Blood, The Journal of the American Society of Hematology 128 (18), 2263-2266, 2016 | 28 | 2016 |
| Prognostic value of low-level MRD in adult acute lymphoblastic leukemia detected by low-and high-throughput methods M Kotrová, J Koopmann, H Trautmann, N Alakel, J Beck, K Nachtkamp, ... Blood Advances 6 (10), 3006-3010, 2022 | 26 | 2022 |
| Noncanonical effector functions of the T-memory–like T-PLL cell are shaped by cooperative TCL1A and TCR signaling S Oberbeck, A Schrader, K Warner, D Jungherz, G Crispatzu, J Von Jan, ... Blood, The Journal of the American Society of Hematology 136 (24), 2786-2802, 2020 | 24 | 2020 |
| Wilms tumor gene 1 (WT1), TP53, RAS/BRAF and KIT aberrations in testicular germ cell tumors L Boublikova, V Bakardjieva-Mihaylova, KS Kramarzova, D Kuzilkova, ... Cancer Letters 376 (2), 367-376, 2016 | 20 | 2016 |
| Automation of amplicon-based library preparation for next-generation sequencing by centrifugal microfluidics JF Hess, M Kotrová, S Calabrese, N Darzentas, T Hutzenlaub, R Zengerle, ... Analytical chemistry 92 (19), 12833-12841, 2020 | 19 | 2020 |
| NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on an MRD-based protocol M Svaton, A Skotnicova, L Reznickova, A Rennerova, T Valova, ... Blood 141 (5), 529-533, 2023 | 18 | 2023 |
| Comparison of minimal residual disease levels in bone marrow and peripheral blood in adult acute lymphoblastic leukemia M Kotrova, A Volland, B Kehden, H Trautmann, M Ritgen, R Wäsch, ... Leukemia 34 (4), 1154-1157, 2020 | 15 | 2020 |
Nikos Darzentasinfspire.org在 uksh.de 的电子邮件经过验证
